Literature DB >> 2759910

A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity.

Y S Zhen1, X Y Ming, B Yu, T Otani, H Saito, Y Yamada.   

Abstract

C-1027, a new macromolecular antitumor antibiotic produced by Streptomyces globisporus C-1027, showed extremely potent cytotoxicity toward cultured cancer cells. Compared in terms of IC50 values, antibiotic C-1027 showed much more potent cytotoxicity than doxorubicin, mitomycin C and neocarzinostatin. Spermatogonial assay, a prescreen for anticancer drugs, was highly sensitive for detection of C-1027. At tolerable doses, C-1027 exhibited marked inhibition on a panel of transplantable tumors in mice, which included leukemia L1210, P388, ascites hepatoma H22, sarcoma 180 and melanoma Harding-Passey.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759910     DOI: 10.7164/antibiotics.42.1294

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  20 in total

1.  Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.

Authors:  Yue-Xin Liang; Wei Zhang; Dian-Dong Li; Hui-Tu Liu; Ping Gao; Yi-Na Sun; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Genes for production of the enediyne antitumor antibiotic C-1027 in Streptomyces globisporus are clustered with the cagA gene that encodes the C-1027 apoprotein.

Authors:  W Liu; B Shen
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Genome neighborhood network reveals insights into enediyne biosynthesis and facilitates prediction and prioritization for discovery.

Authors:  Jeffrey D Rudolf; Xiaohui Yan; Ben Shen
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-29       Impact factor: 3.346

4.  The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3.

Authors:  Yanjun Zhang; Rong Liu; Dongmei Fan; Rizan Shi; Ming Yang; Qingfang Miao; Zhao-Qun Deng; Jun Qian; Yongsu Zhen; Dongsheng Xiong; Jianxiang Wang
Journal:  Cancer Biol Ther       Date:  2015-07-17       Impact factor: 4.742

5.  Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.

Authors:  Xing-Qi Li; Zhi-Gang Ouyang; Sheng-Hua Zhang; Hong Liu; Yue Shang; Yi Li; Yong-Su Zhen
Journal:  J Neurooncol       Date:  2014-05-20       Impact factor: 4.130

6.  Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.

Authors:  Yun-Hong Huang; Bo-Yang Shang; Yong-Su Zhen
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

7.  Pharmacokinetics of C-1027 in mice as determined by TCA-RA method.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Mao-Jin Zhou; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

8.  C-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cells.

Authors:  Terry A Beerman; Loretta S Gawron; Seulkih Shin; Ben Shen; Mary M McHugh
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  DNA damage by C1027 involves hydrogen atom abstraction and addition to nucleobases.

Authors:  Joanna Maria N San Pedro; Terry A Beerman; Marc M Greenberg
Journal:  Bioorg Med Chem       Date:  2012-06-09       Impact factor: 3.641

10.  Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 production of Streptomyces globisporus C-1027.

Authors:  Lifei Wang; Yunfeng Hu; Yanjuan Zhang; Songmei Wang; Zhihui Cui; Yi Bao; Wei Jiang; Bin Hong
Journal:  BMC Microbiol       Date:  2009-01-22       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.